https://transhumanist.ru/index.php?action=history&feed=atom&title=EIF2B2 2026-04-19T15:10:07Z История изменений этой страницы в вики MediaWiki 1.43.6 https://transhumanist.ru/index.php?title=EIF2B2&diff=6462&oldid=prev 2021-05-12T15:31:50Z

<p>Новая страница: «Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta) [EIF2BB] ==Publications== {{medline-entry |t...»</p> <p><b>Новая страница</b></p><div>Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta) [EIF2BB]<br /> <br /> ==Publications==<br /> <br /> {{medline-entry<br /> |title=Mendelian adult-onset leukodystrophy genes in Alzheimer&#039;s disease: critical influence of [[CSF1R]] and [[NOTCH3]].<br /> |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29544907<br /> |abstract=Mendelian adult-onset leukodystrophies are a spectrum of rare inherited progressive neurodegenerative disorders affecting the white matter of the central nervous system. Among these, cerebral autosomal dominant and recessive arteriopathy with subcortical infarcts and leukoencephalopathy, cerebroretinal vasculopathy, metachromatic leukodystrophy, hereditary diffuse leukoencephalopathy with spheroids, and vanishing white matter disease present with rapidly progressive dementia as dominant feature and are caused by mutations in [[NOTCH3]], [[HTRA1]], [[TREX1]], [[ARSA]], [[CSF1R]], [[EIF2B1]], [[EIF2B2]], [[EIF2B3]], [[EIF2B4]], and [[EIF2B5]], respectively. Given the rare incidence of these disorders and the lack of unequivocally diagnostic features, leukodystrophies are frequently misdiagnosed with common sporadic dementing diseases such as Alzheimer&#039;s disease (AD), raising the question of whether these overlapping phenotypes may be explained by shared genetic risk factors. To investigate this intriguing hypothesis, we have combined gene expression analysis (1) in 6 different AD mouse strains (APPPS1, HOTASTPM, HETASTPM, TPM, TAS10, and TAU) at 5 different developmental stages (embryo [E15], 2, 4, 8, and 18 months), (2) in APPPS1 primary cortical neurons under stress conditions (oxygen-glucose deprivation) and single-variant-based and single-gene-based (c-alpha test and sequence kernel association test (SKAT)) genetic screening in a cohort composed of 332 Caucasian late-onset AD patients and 676 Caucasian elderly controls. Csf1r was significantly overexpressed (log2FC &gt; 1, adj. p-value &lt; 0.05) in the cortex and hippocampus of aged HOTASTPM mice with extensive Aβ dense-core plaque pathology. We identified 3 likely pathogenic mutations in [[CSF1R]] TK domain (p.L868R, p.Q691H, and p.H703Y) in our discovery and validation cohort, composed of 465 AD and mild cognitive impairment (MCI) Caucasian patients from the United Kingdom. Moreover, [[NOTCH3]] was a significant hit in the c-alpha test (adj p-value = 0.01). Adult-onset Mendelian leukodystrophy genes are not common factors implicated in AD. Nevertheless, our study suggests a potential pathogenic link between [[NOTCH3]], [[CSF1R]], and sporadic late-onset AD, which warrants further investigation.<br /> |mesh-terms=* Aged<br /> * Aged, 80 and over<br /> * Aging<br /> * Alzheimer Disease<br /> * Animals<br /> * Cerebral Cortex<br /> * Cohort Studies<br /> * European Continental Ancestry Group<br /> * Female<br /> * Genetic Association Studies<br /> * Hippocampus<br /> * Humans<br /> * Leukodystrophy, Metachromatic<br /> * Male<br /> * Mice<br /> * Middle Aged<br /> * Mutation<br /> * Receptor, Notch3<br /> * Receptors, Granulocyte-Macrophage Colony-Stimulating Factor<br /> * Risk Factors<br /> |keywords=* Alzheimer&#039;s disease<br /> * CSF1R<br /> * Mendelian leukodystrophies<br /> * NOTCH3<br /> |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937905<br /> }}</div>

OdysseusBot